CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
U.S. Dengue Testing Market is expected to grow at a steady rate, growing from USD 148.35 Million in 2025 to USD 223.40 Million in 2035 owing to high rapid diagnostic tests’ adoption ratesAustin, April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results